Mississippi Health Center COVID-19 Survey Summary Report

Latest data from September 24, 2021

Number of Health Center respondents = 12 (60% of all Health Centers)

Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.

Patients Tested

Metrics Value
Patients Tested for COVID-19, Virus Detection (PCR, antigen)1 3,922
Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, antigen) 70.36%
Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen)1 425
Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen) 59.71%

Patients by Race and Ethnicity

Race/Ethnicity Patients Tested, Virus Detection (PCR, antigen)2 Patients Tested Positive, Virus Detection (PCR, antigen)2
White, Non-Hispanic/Latino Patients 29.04% 39.06%
White, Hispanic/Latino Patients 0.71% 0.71%
Black/African American, Non-Hispanic/Latino Patients 62.37% 50.82%
Black/African American, Hispanic/Latino Patients 0.13% 0.00%
Asian Patients3 0.36% 0.00%
American Indian/Alaska Native Patients3 0.61% 0.47%
Native Hawaiian/Other Pacific Islander Patients3 0.94% 2.12%
Patients with More than one race3 2.19% 1.41%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 1.63% 2.35%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 1.66% 2.82%
Unreported/Refused to Report Race and Ethnicity 0.36% 0.24%

Patients Vaccinated

Metrics Value
COVID-19 Immunization Series Initiated 728
Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization 82.87%
COVID-19 Immunization Series Completed 1,319
Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization 73.89%
COVID-19 Immunization Series Additional 177
Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine 90.70%

Vaccinations by Race and Ethnicity

Race/Ethnicity Patient COVID-19 Immunization Series Initiated2 Patient COVID-19 Immunization Series Completed2 Patient COVID-19 Immunization Series Additional2
White, Non-Hispanic/Latino Patients 16.90% 25.78% 9.04%
White, Hispanic/Latino Patients 0.14% 0.61% 0.00%
Black/African American, Non-Hispanic/Latino Patients 78.57% 68.61% 64.41%
Black/African American, Hispanic/Latino Patients 0.00% 0.08% 0.00%
Asian Patients3 0.27% 1.06% 0.00%
American Indian/Alaska Native Patients3 0.00% 0.15% 22.03%
Native Hawaiian/Other Pacific Islander Patients3 0.82% 0.45% 1.13%
Patients with More than one race3 1.24% 0.83% 0.56%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 0.69% 1.14% 0.00%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 0.96% 0.83% 1.13%
Unreported/Refused to Report Race and Ethnicity 0.41% 0.45% 1.69%

Testing Logistics

Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, antigen)

Metrics Value
Less Than 1 Hour 8.33%
1 to 24 Hours 41.67%
More Than 24 Hours 50.00%
N/A 0.00%

Vaccine Logistics

Challenges in Deploying the COVID Vaccine

Metrics Value
Financial reimbursement for costs associated with vaccine administration 16.67%
Staffing to administer the vaccine 58.33%
Vaccine confidence 16.67%
Vaccine storage capacity 0.00%
Vaccine supply 0.00%
Other 8.33%
None 25.00%

Operations and Staff

Metrics Value
Health Center Weekly Visits Compared to Pre-COVID 19 Weekly Visits 65.83%
Average Percent of Health Center Visits Conducted Virtually 12.92%

Mobile Vans, Pop-Up Clinics, and School-Based Sites

Metrics Value
Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics 66.67%
Number of Mobile Van Sites 18
Number of Pop-up Clinics 11
Number of School-Based Vaccination Sites 1

Monoclonal Antibody Therapy

Methods in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Direct provision of monoclonal antibody therapies 25.00%
Refer patients to another organization that provides monoclonal antibody therapies 25.00%
None 50.00%

Challenges in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Access to therapeutics 0.00%
Patient awareness/education 0.00%
Staffing capacity 16.67%
Therapy administration/onsite logistics 33.33%
Other 16.67%
None 50.00%

1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.

2 Percentages may not add to 100% due to rounding to the hundredths.

3 Includes Hispanic/Latino and Non-Hispanic/Latino.

Date Last Reviewed:  October 2021